Episurf Medical has announced that…
The new laboratory in Atlanta,…
The company has announced that…
Xigduo XR, a once-daily fixed-dose…
Soliris has been recommended for…
InDex Pharmaceuticals has announced that…
Ultomiris has been approved in…
Koselugo (selumetinib) has been approved…
Ranibizumab biosimilar is being launched…
Calquence, a next generation, selective…
The EpiShuttle is approved by…
Orion Corporation has signed a…
The company has submitted the…
Orientation Marketing has opened a…
The company’s TetraGraph-system has now…
AstraZeneca and Daiichi Sankyo’s Enhertu…